Next-generation sequencing (NGS) in patients (pts) with metastatic colorectal cancer (mCRC): novel mutated genes and differential response to therapy (Alliance)
- Citation:
- Annals of Oncology vol 30 (Supplement_5) v198–v199
- Meeting Instance:
- ESMO 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3663
- Pharmas:
- Genentech, Eli Lily & Co., Pfizer, Sanofi
- Grants:
- U10CA180821, U10CA180882, U10CA180888 and U10CA180830 (SWOG);
- Corr. Author:
- Authors:
- Federico Innocenti Naim Rashid Wancen Mu Fang-Shu Ou Xueping Qu Stefanie Denning Monica Bertagnolli Charles David Blanke Alan P. Venook Omar Kabbarah Heinz-Josef Lenz
- Networks:
- CA011, CA136, LAPS-MA036, LAPS-MN026, LAPS-NC007, OR013
- Study
- CALGB-80405
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: